According to a new discovery, a protein which doubles up as a salt pump at the malaria parasite surface could pave the way for a new class of anti-malarial drugs.
Natalie Spillman from the Research School of Biology (RSB), Australian National University (ANU), said: "It was within a week or two of our identification of the pump protein that a paper came out reporting the discovery of the spiroindolone anti-malarials," Spillman said.
Targets for New Anti-malaria Drugs Identified
Two parasite enzymes called peptidases have been validated as potential anti-malarial drug targets.
Advertisement
Spillman showed that spiroindolones block the parasite's salt pump, causing the cell to fill rapidly with salt.
"We believe the spiroindolones kill the parasite by causing a salt overload," added Spillman, the journal Cell Host and Microbe reports.
Spillman linked up with members of the spiroindolone-development team in Singapore (Novartis Institutes for Tropical Diseases) and the US (Genomics Institute of the Novartis Research Foundation).
![One Child Dead, Over 100 Ill After Taking Malaria Drugs in China]( "One Child Dead, Over 100 Ill After Taking Malaria Drugs in China")
One child died and more than 100 villagers fell ill in southwestern China after they took anti-malarial medicine, state media reported, in the latest product-safety scare.
The spiroindolones are the first genuinely novel class of chemicals to be tested in malaria patients for over 20 years, according to an ANU statement.
The malaria parasite is a single-celled organism that invades the red blood cells of its human host, killing more than a million people each year.
It is becoming increasingly resistant to most of the anti-malarial drugs that are currently in use.
RSB director Kiaran Kirk, senior study author, said: "The malaria parasite's salt pump would seem to be an Achilles heel for the parasite, particularly vulnerable to attack. Knowing this, we can now look for other drugs that block this pump."
Source: IANS
Spillman linked up with members of the spiroindolone-development team in Singapore (Novartis Institutes for Tropical Diseases) and the US (Genomics Institute of the Novartis Research Foundation).
One Child Dead, Over 100 Ill After Taking Malaria Drugs in China
One child died and more than 100 villagers fell ill in southwestern China after they took anti-malarial medicine, state media reported, in the latest product-safety scare.
Advertisement
The spiroindolones are the first genuinely novel class of chemicals to be tested in malaria patients for over 20 years, according to an ANU statement.
The malaria parasite is a single-celled organism that invades the red blood cells of its human host, killing more than a million people each year.
It is becoming increasingly resistant to most of the anti-malarial drugs that are currently in use.
RSB director Kiaran Kirk, senior study author, said: "The malaria parasite's salt pump would seem to be an Achilles heel for the parasite, particularly vulnerable to attack. Knowing this, we can now look for other drugs that block this pump."
Source: IANS
WHO Unveils New Guidelines for Malaria Treatment
The World Health Organisation unveiled Tuesday landmark new measures to counter the misuse of anti-malaria drugs, which is threatening attempts to stifle some 250 million cases a year of the disease.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest General Health News
The Brain Care Score is a tool to evaluate brain health and reduce the risk of brain disorders including dementia and stroke.
Swine influenza A viruses, including subtypes H1N1, H1N2, and H3N2, are prominent among pigs and sporadically transmit to humans.
The microorganism "is a newly identified potential disease-causing agent, possibly originating from or evolving within the dog's microbiome."
Flavanol naturally present in red wine can compromise the proper metabolism of alcohol and lead to a headache.
To reduce bacterial risks, pet owners can switch to a non-raw diet or obtain quality raw meat for cooking before feeding dogs.